Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012208277> ?p ?o ?g. }
- W2012208277 endingPage "606" @default.
- W2012208277 startingPage "601" @default.
- W2012208277 abstract "Many common human mesenchymal tumors, including gastrointestinal stromal tumor (GIST), rhabdomyosarcoma (RMS) and leiomyosarcoma (LMS), feature myogenic differentiation. Here we report that intragenic deletion of the dystrophin-encoding and muscular dystrophy-associated DMD gene is a frequent mechanism by which myogenic tumors progress to high-grade, lethal sarcomas. Dystrophin is expressed in the non-neoplastic and benign counterparts of GIST, RMS and LMS tumors, and DMD deletions inactivate larger dystrophin isoforms, including 427-kDa dystrophin, while preserving the expression of an essential 71-kDa isoform. Dystrophin inhibits myogenic sarcoma cell migration, invasion, anchorage independence and invadopodia formation, and dystrophin inactivation was found in 96%, 100% and 62% of metastatic GIST, embryonal RMS and LMS samples, respectively. These findings validate dystrophin as a tumor suppressor and likely anti-metastatic factor, suggesting that therapies in development for muscular dystrophies may also have relevance in the treatment of cancer." @default.
- W2012208277 created "2016-06-24" @default.
- W2012208277 creator A5015257672 @default.
- W2012208277 creator A5019744308 @default.
- W2012208277 creator A5021244419 @default.
- W2012208277 creator A5023048831 @default.
- W2012208277 creator A5031123252 @default.
- W2012208277 creator A5035089484 @default.
- W2012208277 creator A5037797739 @default.
- W2012208277 creator A5040359760 @default.
- W2012208277 creator A5040783605 @default.
- W2012208277 creator A5048279582 @default.
- W2012208277 creator A5048436189 @default.
- W2012208277 creator A5049104586 @default.
- W2012208277 creator A5050651568 @default.
- W2012208277 creator A5053509144 @default.
- W2012208277 creator A5056266239 @default.
- W2012208277 creator A5060580923 @default.
- W2012208277 creator A5084829609 @default.
- W2012208277 creator A5086786876 @default.
- W2012208277 creator A5089731650 @default.
- W2012208277 creator A5090805414 @default.
- W2012208277 date "2014-05-04" @default.
- W2012208277 modified "2023-10-11" @default.
- W2012208277 title "Dystrophin is a tumor suppressor in human cancers with myogenic programs" @default.
- W2012208277 cites W1510205084 @default.
- W2012208277 cites W1938362079 @default.
- W2012208277 cites W1966103529 @default.
- W2012208277 cites W1967740895 @default.
- W2012208277 cites W1969570221 @default.
- W2012208277 cites W1971143219 @default.
- W2012208277 cites W1988787904 @default.
- W2012208277 cites W1988968354 @default.
- W2012208277 cites W2003670285 @default.
- W2012208277 cites W2005174726 @default.
- W2012208277 cites W2026104663 @default.
- W2012208277 cites W2030379493 @default.
- W2012208277 cites W2034421608 @default.
- W2012208277 cites W2035214704 @default.
- W2012208277 cites W2043398720 @default.
- W2012208277 cites W2044834747 @default.
- W2012208277 cites W2044964290 @default.
- W2012208277 cites W2048119837 @default.
- W2012208277 cites W2052854731 @default.
- W2012208277 cites W2057774884 @default.
- W2012208277 cites W2060072724 @default.
- W2012208277 cites W2063704969 @default.
- W2012208277 cites W2066180106 @default.
- W2012208277 cites W2067596492 @default.
- W2012208277 cites W2070409856 @default.
- W2012208277 cites W2079152675 @default.
- W2012208277 cites W2080595062 @default.
- W2012208277 cites W2086797990 @default.
- W2012208277 cites W2088022023 @default.
- W2012208277 cites W2091477263 @default.
- W2012208277 cites W2101214437 @default.
- W2012208277 cites W2113041439 @default.
- W2012208277 cites W2113491911 @default.
- W2012208277 cites W2115322245 @default.
- W2012208277 cites W2117692326 @default.
- W2012208277 cites W2137714739 @default.
- W2012208277 cites W2140626630 @default.
- W2012208277 cites W2146848597 @default.
- W2012208277 cites W2153606417 @default.
- W2012208277 cites W2155995223 @default.
- W2012208277 cites W2157085976 @default.
- W2012208277 cites W2163239105 @default.
- W2012208277 cites W2165200432 @default.
- W2012208277 cites W2171620774 @default.
- W2012208277 doi "https://doi.org/10.1038/ng.2974" @default.
- W2012208277 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4225780" @default.
- W2012208277 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24793134" @default.
- W2012208277 hasPublicationYear "2014" @default.
- W2012208277 type Work @default.
- W2012208277 sameAs 2012208277 @default.
- W2012208277 citedByCount "130" @default.
- W2012208277 countsByYear W20122082772014 @default.
- W2012208277 countsByYear W20122082772015 @default.
- W2012208277 countsByYear W20122082772016 @default.
- W2012208277 countsByYear W20122082772017 @default.
- W2012208277 countsByYear W20122082772018 @default.
- W2012208277 countsByYear W20122082772019 @default.
- W2012208277 countsByYear W20122082772020 @default.
- W2012208277 countsByYear W20122082772021 @default.
- W2012208277 countsByYear W20122082772022 @default.
- W2012208277 countsByYear W20122082772023 @default.
- W2012208277 crossrefType "journal-article" @default.
- W2012208277 hasAuthorship W2012208277A5015257672 @default.
- W2012208277 hasAuthorship W2012208277A5019744308 @default.
- W2012208277 hasAuthorship W2012208277A5021244419 @default.
- W2012208277 hasAuthorship W2012208277A5023048831 @default.
- W2012208277 hasAuthorship W2012208277A5031123252 @default.
- W2012208277 hasAuthorship W2012208277A5035089484 @default.
- W2012208277 hasAuthorship W2012208277A5037797739 @default.
- W2012208277 hasAuthorship W2012208277A5040359760 @default.
- W2012208277 hasAuthorship W2012208277A5040783605 @default.
- W2012208277 hasAuthorship W2012208277A5048279582 @default.
- W2012208277 hasAuthorship W2012208277A5048436189 @default.